Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 14/20 | 0.62 |
| ▸ | PARP15 | Q460N3 | 4/20 | 0.62 |
| ▸ | PARP4 | Q9UKK3 | 2/20 | 0.62 |
| ▸ | PARP14 | Q460N5 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | PARP16 | Q8N5Y8 | 1/20 | 0.62 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.62 |
| ▸ | PARP2 | Q9UGN5 | 3/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | PARP1 | P09874 | 1/20 | 0.53 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.52 |
| ▸ | MMP13 | P45452 | 1/20 | 0.50 |
| ▸ | PARP3 | Q9Y6F1 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | TNKS | O95271 | 1/20 | 0.49 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22724718 | 1.00 | PARP10 (0.62) | PARP10PARP15PARP4PARP14KMT2A | |
| SCHEMBL24124456 | 0.91 | PARP10 (0.75) | PARP10PARP15PARP4PARP14KMT2A | |
| SCHEMBL24592196 | 0.89 | PARP10 (0.79) | PARP10PARP15PARP4PARP14KMT2A | |
| SCHEMBL3013339 | 0.89 | PARP10 (0.79) | PARP10PARP15PARP4PARP14KMT2A | |
| SCHEMBL4234642 | 0.86 | PARP10 (0.68) | PARP10PARP15PARP4PARP14KMT2A | |
| SCHEMBL22724722 | 0.86 | RAB9A (0.62) | KMT2AALDH1A1MMP13NPC1RAB9A | |
| SCHEMBL24124455 | 0.84 | PARP10 (0.79) | PARP10PARP15PARP4PARP14KMT2A | |
| SCHEMBL22724717 | 0.84 | PARP10 (0.79) | PARP10PARP15PARP4PARP14KMT2A | |
| SCHEMBL24124575 | 0.83 | TDP1 (0.67) | KMT2AALDH1A1CA1CA2MMP13 | |
| SCHEMBL9325864 | 0.82 | ALDH1A1 (0.65) | KMT2AALDH1A1MMP13NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210395209-A1 | NUCLEATING AGENT, SYNTHETIC-RESIN COMPOSITION CONTAINING SAME, AND MOLDED OBJECT THEREOF | ADEKA CORPORATION (JP) | 2021-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210395209-A1 | NUCLEATING AGENT, SYNTHETIC-RESIN COMPOSITION CONTAINING SAME, AND MOLDED OBJECT THEREOF | NOC2L, RIF1, NAP1L1 | PARP10 348/4885PARP15 212/4885PARP4 612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.